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ABSTRACT 
Background: 
Anti-C1q has been associated with systemic lupus erythematosus (SLE) as well as in 
other connective tissue diseases. They have been considered as a marker for disease 
activity and presence of nephritis in previous studies 
Objectives:  
Aim of this study was to determine the prevalence of anti- C1q antibodies in the 
pediatric SLE population and to determine clinical associations of elevated anti- C1q 
antibody levels especially with lupus nephritis. 
Methods: 
Sera of 150 pediatric SLE patients who fulfilled ACR criteria for SLE were recruited.  
After obtaining informed consent, blood samples were tested for anti- C1q antibody 
by commercially available ELISA kit. Prevalence of anti-C1q and its association with 
lupus nephritis were determined. . 
Results: 
Out of total 150 children with SLE, anti- C1q positivity was present in 95 
children(64%), at a cut off value of 20U/ml. Children with proteinuria, low C3, low 
C4 and anti dsDNA positivity had were significantly more likely to have anti- C1q 
antibody positivity.Children with lupus nephritis were significantly more likely to 
have anti C1q antibodies positive than children without renal involvement (74% vs. 
51% , p= 0.02). Among the children with lupus nephritis, children with active renal 
disease were more likely to haveanti- C1qpositivity than in children with quiescent 
disease (88% vs. 53% , p= 0.002). Anti-C1q antibodies had a sensitivity of 74% and 
specificity of 54% at a cut off value of 22U/L , for renal disease in pSLE 
Conclusion: 
Out study confirms previous findings of the association of anti-C1q antibodies with 
nephritis and disease activity in pSLE.  Anti-C1q antibody titers were found to have 
positive correlation with renal disease in children with pediatric SLE, and could be 
used as an adjunctive biomarker in monitoring disease activity in children with lupus 
nephritis 
. 
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